Cargando…

Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases

We describe 3 fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis and death after the administration of oxaliplatin as part of the FOLFOX regimen. Due to the widespread use of oxaliplatin in oncology, clinicians should be aware of the risk and severity of oxalipatin-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Pontes, L.B., Armentano, D.P.D., Soares, A., Gansl, R.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337737/
https://www.ncbi.nlm.nih.gov/pubmed/22539922
http://dx.doi.org/10.1159/000337030
_version_ 1782231115551997952
author Pontes, L.B.
Armentano, D.P.D.
Soares, A.
Gansl, R.C.
author_facet Pontes, L.B.
Armentano, D.P.D.
Soares, A.
Gansl, R.C.
author_sort Pontes, L.B.
collection PubMed
description We describe 3 fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis and death after the administration of oxaliplatin as part of the FOLFOX regimen. Due to the widespread use of oxaliplatin in oncology, clinicians should be aware of the risk and severity of oxalipatin-induced interstitial pneumonia.
format Online
Article
Text
id pubmed-3337737
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-33377372012-04-26 Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases Pontes, L.B. Armentano, D.P.D. Soares, A. Gansl, R.C. Case Rep Oncol Published: February, 2012 We describe 3 fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis and death after the administration of oxaliplatin as part of the FOLFOX regimen. Due to the widespread use of oxaliplatin in oncology, clinicians should be aware of the risk and severity of oxalipatin-induced interstitial pneumonia. S. Karger AG 2012-02-29 /pmc/articles/PMC3337737/ /pubmed/22539922 http://dx.doi.org/10.1159/000337030 Text en Copyright © 2012 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: February, 2012
Pontes, L.B.
Armentano, D.P.D.
Soares, A.
Gansl, R.C.
Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases
title Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases
title_full Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases
title_fullStr Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases
title_full_unstemmed Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases
title_short Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases
title_sort fatal pneumonitis induced by oxaliplatin: description of three cases
topic Published: February, 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337737/
https://www.ncbi.nlm.nih.gov/pubmed/22539922
http://dx.doi.org/10.1159/000337030
work_keys_str_mv AT ponteslb fatalpneumonitisinducedbyoxaliplatindescriptionofthreecases
AT armentanodpd fatalpneumonitisinducedbyoxaliplatindescriptionofthreecases
AT soaresa fatalpneumonitisinducedbyoxaliplatindescriptionofthreecases
AT ganslrc fatalpneumonitisinducedbyoxaliplatindescriptionofthreecases